IL10 and acute myeloid leukemia: All of the above data support the hypothesis that the increase in IL-10+ Th17 cells in AML is a mechanism developed by the disease to create an immunosuppression state which, given the stem-like features and long life of Th17 cells [14, 37], may be durable and ultimately favor infections, protecting leukemia cells from immune control.